Dr. rer. nat. Arif Bülent Ekici

Institute of Human Genetics

Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors (2015) Rudolph A, Milne RL, Truong T, Knight JA, Seibold P, Flesch-Janys D, Behrens S, et al. Journal article Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk (2015) Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, Michailidou K, et al. Journal article Chromatin-Remodeling-Factor ARID1B Represses Wnt/?-Catenin Signaling (2015) Vasileiou G, Ekici AB, Urebe S, Zweier C, Hoyer J, Engels H, Behrens J, et al. Journal article Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer (2015) Kabisch M, Bermejo JL, Duennebier T, Ying S, Michailidou K, Bolla MK, Wang Q, et al. Journal article IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling (2015) Allgäuer A, Schreiner E, Ferrazzi F, Ekici AB, Gerbitz A, Mackensen A, Voelkl S Journal article Identification of novel genetic markers of breast cancer survival (2015) Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, et al. Journal article A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density (2015) Rudolph A, Fasching P, Behrens S, Eilber U, Bolla MK, Wang Q, Thompson D, et al. Journal article Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study (2015) Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, et al. Journal article Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) Orr N, Dudbridge F, Dryden N, Maguire S, Novo D, Perrakis E, Johnson N, et al. Journal article Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study (2015) Hein A, Lambrechts D, Von Minckwitz G, Haeberle L, Eidtmann H, Tesch H, Untch M, et al. Journal article